Stress has become a constant background noise in modern life, yet most of us still rely on vague gut checks to know when it ...

Amylyx Stock is up a staggering 166% over the past year, and this biotech-focused hedge fund is still doubling down.

This article collection focuses on the rapidly emerging utilization of artificial intelligence (AI) to revolutionize cardiovascular disease prediction and ...

Continuous glucose monitoring (CGM) is underutilized in non-insulin-treated type 2 diabetes (T2D) despite evidence of ...

Kymera shows strong KT-621 Phase 1b efficacy, solid safety, platform validation, cash runway and growth potential in key ...

Data integrity is the backbone of every clinical trial, ensuring that research truly benefits patients and advances medical science. When information is accurate, complete, and transparent, doctors ...

And that was just with one payer, for one year. What's more, the health system's excellent HEDIS numbers earned it the ...

RNA-based therapeutics face challenges in bioanalysis, with experts recommending strategies to improve LC–MS performance and standardize ADME and DMPK practices. GLP-1 therapies require careful ...

Iolyx Therapeutics and Laboratoires Théa (Théa), through support from its subsidiary Théa Open Innovation, have entered into ...

Objective To develop prediction models for short-term outcomes following a first acute myocardial infarction (AMI) event (index) or for past AMI events (prevalent) in a national primary care cohort.

The Centers for Medicare & Medicaid Services (“CMS”), through the CMS Innovation Center (“CMMI”), has announced the ACCESS Model—Advancing ...

BJC Health next chapter highlights integration milestones and strategic plans as the system advances its presence in Missouri markets heading into 2026.